Hyperliquid group asks court to toss CME suit against CFTC

Hyperliquid's policy group asked a court to throw out CME Group's lawsuit against the CFTC. The Block reported the move on Sept. 9, in a story centered on perpetual futures and who gets to offer them in the United States. That matters because CME is an established regulated exchange and the CFTC is its regulator. So a suit between the two could shape the rules for a whole product class.

Perpetual futures never expire

A perpetual future is a bet on a coin's price that never settles on a fixed date. Traders post collateral, called margin, and the position stays open until they close it or it gets liquidated. So the contract needs a tool to stay near the spot price. It uses a funding payment, a small fee that flows from the crowded side to the other side every few hours. If longs pile in, they pay shorts. And if shorts pile in, they pay longs. It's automatic, and it pulls the perp price back toward the real market. That design is why crypto traders like perps. They can hold exposure without rolling contracts each month. But leverage cuts both ways, and a small move can wipe out margin fast.

CME took its own regulator to court

CME sued the CFTC, and Hyperliquid's policy center now wants that case dismissed. The Block described the filing as support for the agency, with the policy group arguing CME's case would hold back new builders. A request to dismiss asks the judge to end a case early. The court takes the plaintiff's stated facts as true for now and asks if they still add up to a legal violation. If the answer is no, the case stops there. If the answer is yes, it moves into full briefing and evidence. That's why dismissal fights matter even before anyone argues the merits. The full claims in CME's suit were not detailed in the material available for this article. The court, the docket number, and any hearing date were not public in that material either.

Hyperliquid says incumbents should not write the rules

The policy center's argument, The Block, is that CME is trying to freeze out innovation. In plain terms, it says an established venue is using court action to keep newer ways of offering perps off the table. That stance fits Hyperliquid's roots. It's known as a venue built around perpetual trading, so a U.S. rule that limits perps would hit close to home. It doesn't mean the group speaks for the CFTC, only that their interests line up here. Support like this often comes as a friend-of-the-court brief. That's a filing from an outsider that tells the judge why the ruling would matter beyond the two named parties. It doesn't make the outsider a party to the case. But judges do read these briefs, especially when they explain how a product actually works in practice. If the court dismisses the case, the CFTC keeps its current path on perps without a court ordering it to change course. If it denies dismissal, both sides will argue the underlying legal questions in full. Watch the docket for the judge's order on the dismissal request. A grant ends CME's challenge at this stage, while a denial pushes the fight into full merits briefing.